Check out your Company Bowl for anonymous work chats.
Strong growth and sustained high profitability in 2025 In 2025, Bachem achieved in local currencies a sales growth of 19.2% and an underlying EBITDA margin of 30.2%, supported by a strong order intake and solid execution of Operational Excellence initiatives. Key highlights: • Reported sales: CHF 695.1m (+14.8%) • Reported EBITDA: CHF 214.7m (+21.8%), with underlying EBITDA margin at 28.6% • Continued investments (CHF 332.6m) in our global production network • Successful inspection of the first part of Building K, an important milestone for future growth Anne-Kathrin Stoller, CEO: “We can look back on a year of strong sales growth and sustained high profitability. Demand for our products and services remains strong. Targeted operational improvements as part of our Operational Excellence initiatives have enabled us not only to significantly increase the capacity of our existing plants, but also to further improve our cost structure. The continuous growth is both a reflection of the trust our customers place in us and the result of the dedication and expertise of our teams worldwide.” 🔗 Read more about our 2025 Annual Results: https://lnkd.in/ejt-_8_Z
“WOMEN IN BACHEM” Women in Bachem (WIB) is a group of women working at Bachem who offer support to other women in developing professionally at Bachem. Our workforce currently comprises only 30% of women, and the higher up the organization, the fewer women. In some of our functions and sites, the proportion is surprising. WIB wants to contribute to the company’s efforts toward a better balance between men and women in different disciplines and leadership positions and foster personal development supporting career progression. The idea of creating this community was first discussed over a coffee in early 2023, and very soon, a small group of women agreed to join and work on it. Current members of WIB found each other through word of mouth and appreciate each other for their drive, leadership, professionalism, and community spirit.
Happy International Women’s Day! We took the chance to sit down with some of Bachem’s leaders to discuss their views on how companies like Bachem can tap into the potential of women in the “STEM” fields (science, technology, engineering, and mathematics) and what advice they have for young women looking to make a career in this area. Thank you Julie Marley, Divina Peralta, Karin Wertz, Aya Ito & Manuela Schneider-Höfferer for your insights.
With Honor and Gratitude, We Remember.
It is a great pleasure to announce that Bachem has been awarded a gold medal rating for sustainability by EcoVadis.🏆 This places Bachem among the 5% of the most sustainable companies assessed by EcoVadis & among the top 2% of companies in the pharmaceutical supplier sector.👏 #Bachem #Sustainability #Pharma
We are so proud to have you as part of our Bachem family. Congratulations on achieving your milestone anniversary! We know you have worked hard for this accomplishment and we truly appreciate your dedication.
Bachem presented annual results for the year 2021 and over half a billion sales for the first time in company history. Our Executive Team shares their thoughts on 2021, an outlook into 2022 and of course a big thank you to all at
Happy New Year!
Emerging as a new treatment option in rare and orphan disease areas, oligonucleotides have matured into a drug class with a broad indication spectrum. The promise of oligonucleotides making a difference to an increasing number of patients. With decades of experience in the development, production and regulatory support of APIs, Bachem is extending its focus from peptides to oligonucleotides which leads overall to a transformation of the organization. As can be expected from Bachem, this transformation is being executed meticulously, with a strong focus on innovation and quality. Our aim is to be the first-choice oligonucleotide manufacturer.
Bachem - A Great Place to Work.
